The Technical Analyst
Select Language :
Jounce Therapeutics Inc [JNCE]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Jounce Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Jounce Therapeutics Inc is listed at the  Exchange

0.00% $1.880

America/New_York / 3 mai 2023 @ 16:00


Jounce Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 98.95 mill
EPS: -0.960
P/E: -1.958
Earnings Date: Aug 02, 2023
SharesOutstanding: 52.64 mill
Avg Daily Volume: 3.47 mill
RATING 2023-05-05
A
Buy
RATINGS
Rating CashFlow: Buy
Return On Equity: Strong Buy
Return On Asset: Strong Buy
DE: Neutral
P/E: Buy
Price To Book: Sell
QUARTER GROWTHS
3/214/211/222/223/224/22
Revenuen/an/an/an/a
Gr.Profitn/an/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -1.958 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.33x
Company: PE -1.958 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 1.798 - 1.962

( +/- 4.36%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-05-03 Concentra Biosciences, Llc Buy 10 000 Common Stock
2023-05-03 Tang Kevin C Buy 10 000 Common Stock
2023-05-03 Tang Kevin C Sell 5 300 087 Common Stock
2023-05-03 Concentra Biosciences, Llc Buy 0 Common Stock
2023-05-03 Salter-cid Luisa Sell 20 000 Stock Option (Right to Buy)
INSIDER POWER
-96.23
Last 98 transactions
Buy: 1 025 987 | Sell: 8 913 091

Forecast: 01:40 - $1.945

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $1.880 (0.00% )
Volume 11.60 mill
Avg. Vol. 3.47 mill
% of Avg. Vol 334.62 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Jounce Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for Jounce Therapeutics Inc

RSI

Intraday RSI14 chart for Jounce Therapeutics Inc

Last 10 Buy & Sell Signals For JNCE

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Jounce Therapeutics Inc

JNCE

Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid tumors. It is also developing JTX-8064, an antibody that binds to leukocyte immunoglobulin like receptor B2, which is a cell surface receptor expressed on macrophages; JTX -1484 for myeloid; and JTX-1811, an anti-CCR8 monoclonal antibody designed to selectively deplete intra-tumoral T regulatory cells in the tumor microenvironment. Jounce Therapeutics, Inc. was incorporated in 2012 and is headquartered in Cambridge, Massachusetts.

Last 10 Buy Signals

Date Signal @
KDAUSDMar 29 - 05:44$1.413
GLMRUSDMar 29 - 05:440.490
BATUSDMar 29 - 05:45$0.329
CTXCUSDMar 29 - 05:44$0.459
WOOUSDMar 29 - 05:43$0.453
SFPUSDMar 29 - 05:43$0.776
RPLUSDMar 29 - 05:43$31.06
ROUTEUSDMar 29 - 05:434.29
STRKUSDMar 29 - 05:43$14.16
RNDRUSDMar 29 - 05:4310.90

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.